chr10-102065990-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_024747.6(HPS6):​c.516G>A​(p.Gly172Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0966 in 1,600,686 control chromosomes in the GnomAD database, including 8,355 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.079 ( 604 hom., cov: 33)
Exomes 𝑓: 0.098 ( 7751 hom. )

Consequence

HPS6
NM_024747.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.0430

Publications

11 publications found
Variant links:
Genes affected
HPS6 (HGNC:18817): (HPS6 biogenesis of lysosomal organelles complex 2 subunit 3) This intronless gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. This protein interacts with Hermansky-Pudlak syndrome 5 protein. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 6. [provided by RefSeq, Jul 2008]
HPS6 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 6
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • Hermansky-Pudlak syndrome without pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 10-102065990-G-A is Benign according to our data. Variant chr10-102065990-G-A is described in ClinVar as Benign. ClinVar VariationId is 163683.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.043 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.142 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPS6NM_024747.6 linkc.516G>A p.Gly172Gly synonymous_variant Exon 1 of 1 ENST00000299238.7 NP_079023.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPS6ENST00000299238.7 linkc.516G>A p.Gly172Gly synonymous_variant Exon 1 of 1 6 NM_024747.6 ENSP00000299238.5 Q86YV9

Frequencies

GnomAD3 genomes
AF:
0.0787
AC:
11970
AN:
152128
Hom.:
604
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0184
Gnomad AMI
AF:
0.0746
Gnomad AMR
AF:
0.0768
Gnomad ASJ
AF:
0.0726
Gnomad EAS
AF:
0.151
Gnomad SAS
AF:
0.0294
Gnomad FIN
AF:
0.119
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.108
Gnomad OTH
AF:
0.0775
GnomAD2 exomes
AF:
0.0867
AC:
20265
AN:
233706
AF XY:
0.0849
show subpopulations
Gnomad AFR exome
AF:
0.0166
Gnomad AMR exome
AF:
0.0635
Gnomad ASJ exome
AF:
0.0778
Gnomad EAS exome
AF:
0.157
Gnomad FIN exome
AF:
0.115
Gnomad NFE exome
AF:
0.107
Gnomad OTH exome
AF:
0.0866
GnomAD4 exome
AF:
0.0985
AC:
142623
AN:
1448440
Hom.:
7751
Cov.:
34
AF XY:
0.0964
AC XY:
69531
AN XY:
720942
show subpopulations
African (AFR)
AF:
0.0155
AC:
519
AN:
33468
American (AMR)
AF:
0.0647
AC:
2881
AN:
44544
Ashkenazi Jewish (ASJ)
AF:
0.0743
AC:
1938
AN:
26086
East Asian (EAS)
AF:
0.112
AC:
4450
AN:
39668
South Asian (SAS)
AF:
0.0241
AC:
2080
AN:
86134
European-Finnish (FIN)
AF:
0.117
AC:
4804
AN:
40966
Middle Eastern (MID)
AF:
0.0320
AC:
184
AN:
5750
European-Non Finnish (NFE)
AF:
0.108
AC:
120064
AN:
1111562
Other (OTH)
AF:
0.0946
AC:
5703
AN:
60262
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
8815
17630
26444
35259
44074
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4296
8592
12888
17184
21480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0786
AC:
11966
AN:
152246
Hom.:
604
Cov.:
33
AF XY:
0.0777
AC XY:
5786
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0184
AC:
765
AN:
41574
American (AMR)
AF:
0.0767
AC:
1174
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0726
AC:
252
AN:
3470
East Asian (EAS)
AF:
0.150
AC:
777
AN:
5164
South Asian (SAS)
AF:
0.0294
AC:
142
AN:
4826
European-Finnish (FIN)
AF:
0.119
AC:
1263
AN:
10598
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.108
AC:
7351
AN:
67994
Other (OTH)
AF:
0.0786
AC:
166
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
572
1143
1715
2286
2858
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0934
Hom.:
1013
Bravo
AF:
0.0729
Asia WGS
AF:
0.0690
AC:
239
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Apr 15, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gly172Gly in exon 1 of HPS6: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 9.9% (847/8590) of Eu ropean American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs3737243). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hermansky-Pudlak syndrome 6 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
1.6
DANN
Benign
0.81
PhyloP100
-0.043
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3737243; hg19: chr10-103825747; COSMIC: COSV54625134; API